The BAP test and the global assessment of oxidative stress ... - Medial

More documents

Recommendations

Info

absorption of nutrients, etc.). In these casesalso, the aim of the BAP test is to identify andto prevent oxidative stress and its unwantedconsequences (early aging, diseases) (57).Moreover, the BAP test should be carriedout on all patients with oxidative stress-relateddiseases (more than one hundred), such asAlzheimer’s disease, Parkinson’s disease,stroke, infarction, Crohn’s diseases, rheumatoidarthritis, AIDS, some cancers, etc. In all thesecases, the aim of the BAP test is to monitoroxidative stress and to prevent itsconsequences, by monitoring the efficacy ofspecific therapy, either alone or with aconcomitant antioxidant treatment (54). Onthis subject, it must be underlined that in manyof above mentioned diseases, all almost havinga chronic course, oxidative stress tends toraise the role of an additional health riskfactor. Therefore, it must be controlled in orderto optimize results of any treatment. Forinstance, the evidence, by means of BAP test,of a reduced biological antioxidant potential inhypertensive patients indicates a persistentimpairment of physiological defenses againstROS, which can be responsible for anincomplete control of the current disease bythe current anti-hypertensive treatment. Sucha finding suggests to the clinician an integratedtherapeutic approach, in which should be takeplace not only conventional, medical and/orsurgical treatments, but also the correction oflife-style and, eventually, the intake ofantioxidants.Finally, ideal candidates for the BAP testare all the subjects that undergopharmacotherapy (e. g. with chemotherapeuticals,hormone replacement therapy,contraceptive pill, etc.), surgical interventions(e. g. organ transplantation, by-pass, etc.),including dialysis, all conditions being able tofavor oxidative stress by increasing the dailyrequirements of antioxidants (53, 54).In all these conditions, the aim is toidentify and to prevent oxidative stress and itsconsequences, and, particularly, to monitor theefficacy of eventual current measures with theultimate objective of preventing oxidativetissue damage (56).Furthermore, according to the guidelines ofthe International Observatory of OxidativeStress, Free Radicals and Antioxidant Systems,the BAP test is very useful, together d-ROMstest, in the so-called global assessment ofoxidative stress, now very easy to performgrace to a specific diagnostic algorithm (41,58).In this situation, when d-ROMs value isincreased, an optimal value of BAP test shouldrequire the dosing of a single antioxidant.Alternatively, if such a dosing is not available,we suggest a mix of antioxidants according tothe RDA tables. This should enable theantioxidant defenses to balance the increasedoxidative status, as detected by the increasedd-ROMs test values, especially when more thanone risk factor is present (e. g. exposition toradiations, cigarette smoke, pollutants, etc.).11. Concluding remarksScientific evidence shows that BAP test isvery useful in the assessment of antioxidantactivity of blood plasma. AAccording to the wide available scientificliterature BAP test was validated by ESR/EPRand provided results that largely parallel tothose of FRAP test, against which it appearsquicker and simpler to perform. Indeed, thepreparation and management of the FRAPreagents is a step somewhat complex,compared to that of BAP test, so that manualprocedure of FRAP test can increase analyticalvariability. Moreover, a further increase ofanalytical accuracy was recently reached bythe application of BAP test to automaticanalytical devices.Finally, according to the novel concept ofglobal oxidative stress assessment, the BAPtest is a reliable assay able to integrate theresults of d-ROMs test, which allows for theassessing of the total oxidant status of bloodplasma.18www.fras4evolvo.it
References1. Halliwell B, Gutteridge JMC. Free radicals inbiology and medicine. 2 nd Edn, ClarendonPress, Oxford. 1989.2. Cadenas E, Packer L. Handbook ofantioxidants. Marcel Dekker, Inc. 1996.3. Halliwell B, Gutteridge JMC, Cross CE. Freeradicals, antioxidants, and human disease:where are we now? J Clin Lab Med. 1992.119: 598–620.4. Valko M, Leibfritz D, Moncol J, Cronin MT,Mazur M, Telser J. Free radicals andantioxidants in normal physiological functionsand human disease. Int J Biochem Cell Biol.2007. 39 (1): 44–84.5. Cao G, Prior RL. Comparison of differentanalytical methods for assessing totalantioxidant capacity of human serum. ClinicalChemistry. 1998. 44 (6): 1309–1315.6. Olson J L. Benefits and liabilities of vitamin Aand carotenoids. J Nutr. 1996. 126: 1208S–1212S.7. Schwartz JL. The dual role of nutrients asantioxidants and prooxidants: their effect ontumor cell growth. J Nutr. 1996. 126: 1221S–1227S8. Wayner DDM, Burton GW, Ingold KU, LockeS. Quantitative measurement of the total,peroxyl radical-trapping antioxidant capacity ofhuman blood plasma by controlledperoxidation. FEBS Lett. 1985. 187: 33–7.9. Glazer AN. Phycoerythrin fluorescence-basedassay for reactive oxygen species. MethodsEnzymol. 1990. 186. 161–8.10. Cao G, Alessio HM, Cutler RG. Oxygenradicalabsorbance capacity assay forantioxidants. Free Rad Biol Med. 1993.14:303–11.11. Cao G, Verdon CP, Wu AHB, Wang H, PriorRL. Automated oxygen radical absorbance19capacity assay using the COBAS FARA II. ClinChem. 1995. 41: 1738–44.12. Rice-Evans C, Miller NJ. Total antioxidantstatus in plasma and body fluids. MethodsEnzymol. 1994. 234: 279–93.13. Miller NJ, Rice-Evans C, Davies MJ,Gopinathan V, Milner A. A novel method formeasuring antioxidant capacity and itsapplication to monitoring the antioxidant statusin premature neonates. Clin Sci. 1993. 84:407–12.14. Ghiselli A, Serafini M, Maiani G, Assini E,Ferro-Luzzi A. A fluorescence-based method formeasuring total plasma antioxidant capability.Free Rad Biol Med. 1994. 18: 29–36.15. Whitehead TP, Thorpe GHG, Maxwell SRJ.Enhanced chemiluminescent assay forantioxidant capacity in biological fluids. AnalChim Acta. 1992. 266: 265–77.16. Trotti R, Carratelli M, Barbieri M, Micieli G,Bosone D, Rondanelli P, Bo P. Oxidative stressand thrombophilic condition in alcoholicswithout severe liver disease. 2001.Haematologica. 86: 85-91.17. Carratelli M, Porcaro R, Ruscica M, DeSimone E, Bertelli AAE, Corsi MM. ReactiveOxygen Metabolites (ROMs) and prooxidantstatus in children with Down Syndrome.International Journal of Clinical PharmacologyResearch. 2001. 21 (2): 79-84.18. Brambilla G, Fiori M, Archetti LI. Evaluationof the oxidative stress in growing pigs bymicroplate assays. J Vet Med A. 2001. 48: 33-38.19. MERCK CHEMICAL Database. 2003.20. Dohi K, Satoh K, Ohtaki H, Shioda S,Miyake Y, Shindo M, Aruga T. Elevated plasmalevels of bilirubin in patients with neurotraumareflect its pathophysiological role in free radicalscavenging. In Vivo. 2005. 19 (5): 855–860.www.fras4evolvo.it
Page 1 and 2: Eugenio Luigi IorioA short reviiewR
Page 3 and 4: Table of ContentsPreface and acknow
Page 5 and 6: 1. IntroductionThe blood of Vertebr
Page 7 and 8: different analytical approach (e. g
Page 9 and 10: On the other hand, in experimental
Page 12 and 13: In particular, 140 Labrador Retriev
Page 14 and 15: µEq/L25002000150010005000Before di
Page 16 and 17: 8. Clinical studies on AnimalsGrowi
Page 20 and 21: 21. Benzie IFF, Strain JJ. The ferr
Page 22 and 23: 53. Carratelli M, Iorio EL, Bianchi
Page 24: F R A S 4 EVOLVO SYSTEMFREE RADICAL

The BAP test and the global assessment of oxidative stress ... - Medial

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?